It’s not unheard of for drugs to be developed for one ailment and be used to treat others. It’s fairly common, after extensive research and testing, for drugs to be used to treat a blanket of issues. However, another approach by big pharma is raising ethical and legal concerns and their new claims that their First Amendment rights of free speech allows them to market off-label purposes for drugs to doctors. An article by Keith A. Spencer in Salon, highlights a recent case that used free speech to defend untested off-label drug claims. The article was originally published on FairWarning and it says the new free speech defense is making waves in Washington.
The Caronia Case